ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 161 filers reported holding ANTARES PHARMA INC in Q4 2019. The put-call ratio across all filers is 5.95 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 6,400,000 | $13,312,000 | 4.78% |
| GREAT POINT PARTNERS LLC | 2,800,000 | $5,824,000 | 2.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,389,789 | $38,251,000 | 1.27% |
| WILLIAM HARRIS INVESTORS INC | 1,534,283 | $3,191,000 | 0.89% |
| Broadfin Capital, LLC | 7,575,000 | $15,756,000 | 0.85% |
| Lombard Odier Asset Management (USA) Corp | 1,000,000 | $2,080,000 | 0.15% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,665,738 | $3,465,000 | 0.14% |
| JW Asset Management, LLC | 142,198 | $296,000 | 0.09% |
| Donald L. Hagan, LLC | 44,000 | $92,000 | 0.09% |
| DAFNA Capital Management LLC | 45,000 | $94,000 | 0.08% |